chr17-18171709-T-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_016239.4(MYO15A):āc.10154T>Cā(p.Val3385Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000223 in 1,612,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.10154T>C | p.Val3385Ala | missense_variant | 63/66 | ENST00000647165.2 | NP_057323.3 | |
MYO15A | XM_017024715.3 | c.10157T>C | p.Val3386Ala | missense_variant | 61/64 | XP_016880204.1 | ||
MYO15A | XM_017024714.3 | c.10094T>C | p.Val3365Ala | missense_variant | 60/63 | XP_016880203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO15A | ENST00000647165.2 | c.10154T>C | p.Val3385Ala | missense_variant | 63/66 | NM_016239.4 | ENSP00000495481.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152084Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000445 AC: 11AN: 247302Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134644
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1460740Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 726718
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152084Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 28, 2014 | The Val3385Ala variant in MYO15A has not been previously reported in individuals with hearing loss, but has been identified in 0.03% (1/4034) of African America n chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.ed u). Computational prediction tools and conservation analyses suggest that the V al3385Ala variant may not impact the protein, though this information is not pre dictive enough to rule out pathogenicity. In summary, the clinical significance of the Val3385Ala variant is uncertain. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.10154T>C (p.V3385A) alteration is located in exon 63 (coding exon 62) of the MYO15A gene. This alteration results from a T to C substitution at nucleotide position 10154, causing the valine (V) at amino acid position 3385 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at